14-10-2026 /
International comparative study involving 279 patients meets its primary endpoint, demonstrating comparable lesion detection and diagnostic categorization, approximately 80% shorter procedure time, and significantly improved patient comfort. 86% of patients would prefer an examination with nu:view over conventional breast MRI.
A prospective, intraindividual, multicenter, international clinical study has directly compared contrast-enhanced spiral breast CT (CE-SBCT) using nu:view with contrast-enhanced breast MRI (CE-MRI) across major indications for breast MRI.
The study involved 279 patients who underwent both examinations, allowing a direct comparison of diagnostic performance, procedure duration, and patient experience.
Key Study Findings
Non-inferiority to breast MRI demonstrated
CE-SBCT achieved the study’s primary endpoint, demonstrating non-inferiority to CE-MRI in BI-RADS assessment at both whole-breast and lesion level. The study also showed comparable lesion detection, diagnostic categorization, and breast density assessment.
86% of patients preferred CE-SBCT
Following both examinations, 86% of patients indicated a preference for CE-SBCT over CE-MRI. CE-SBCT also received significantly more favorable ratings across all evaluated comfort parameters, including overall examination experience, device comfort, noise, available space, and perceived examination duration.
Approximately 80% shorter procedure time
The mean total procedure duration was 4 minutes for CE-SBCT compared with 20 minutes for CE-MRI, representing an approximately 80% reduction.
New clinical evidence for breast imaging
Breast MRI is widely recognized for its high sensitivity and plays an important role in complex diagnostic settings. Demonstrating non-inferiority to CE-MRI in the study’s primary endpoint is therefore an important finding for the clinical evaluation of CE-SBCT.
Together, these results provide further evidence on the diagnostic performance, workflow efficiency, and patient experience of nu in comparison with breast MRI.
Read the full press release
Explore the study: ClinicalTrials.gov – NCT05989022
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
